C., Riess F., Shokraie C.F., Classen B., Kreikemeyer T., Fiedler C., Junghanss C., Maletzki Supplementary Material for: Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies Arginine auxotrophy occurs in certain tumor types and is usually caused by the silencing of <i>argininosuccinate synthetase</i> 1 or <i>arginine lyase</i> genes. Such tumors are often associated with an intrinsic chemoresistance and thus a poor prognosis. Arginine auxotrophy however renders these tumors vulnerable to treatment with arginine-degrading enzymes. Among the most frequently applied arginine-degrading agents are bacterial arginine deiminases (ADI). The anti-cancerous effects of ADI derived from different bacteria were extensively studied in numerous preclinical cell culture and xenograft models. <i>Mycoplasma</i>-derived ADI-PEG20 is most commonly used and is currently under clinical investigation as a single agent therapeutic as well as in combination with different antineoplastic compounds. Mechanistically, ADI is capable of reducing metabolic activity in tumor cells, contributing to autophagy, senescence and apoptosis in arginine auxotrophic cells. Although clinical trials are promising, the resistance development upon initial treatment response is an increasing challenge. Furthermore, interference of ADI with the tumor microenvironment is poorly understood. In the present review, we outline recent experimental ADI-based treatment approaches and their translation into the clinic. Furthermore, we summarize new insights into the molecular mechanisms underlying the anti-cancer effects of ADI that might facilitate the refinement of ADI-based combination therapy approaches. Arginine-auxotrophy;Arginine deiminase;Therapy resistance;Combination therapy;Tumor microenvironment 2018-11-22
    https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Arginine-Depleting_Enzymes_An_Increasingly_Recognized_Treatment_Strategy_for_Therapy-Refractory_Malignancies/7375853
10.6084/m9.figshare.7375853.v1